Nieto-Martínez Ramfis, Inés Marulanda María, González-Rivas Juan P, Ugel Eunice, Durán Maritza, Barengo Noel, Aschner Pablo, Patiño Mario, López Gómez Luis, Monsalve Pedro, Marcano Héctor, Florez Hermes
Invest Clin. 2017 Mar;58(1):56-69.
The EVESCAM (EstudioVenezolano de Salud Cardio-Metabólica) is the first national, population survey in Venezuela, designed to examine the prevalence of diabetes and cardio-metabolic risk factors and its relationship with lifestyle. It is a cross-sectional, cluster sampling study, which recruited 4454 participants aged ≥ 20 years. The data were collected in community health-care centers by trained health professionals and medical students. The data collected from each subject included, after informed consent, structured questionnaires (clinical, demographic, physical activity, nutritional and psychological), anthropometric measurements (weight, height and waist circumference), body fat by bioelectrical impedance, hand grip, blood pressure, electrocardiogram, and biochemical measurements (standard 75 g oral glucose tolerance test, total cholesterol, HDL-cholesterol, LDL-cholesterol and triglycerides). The data will be used to estimate the prevalence of overweight, obesity, prediabetes, diabetes, hypertension, dyslipidemias, sarcopenia and metabolic syndrome; and to examine their relationships with lifestyle factors. The risk of coronary heart disease and impaired glucose regulation will be estimated using the Framingham Coronary Heart Disease Risk Score and the Latin America adaptation of the Finnish Diabetes Risk Score (LA-FINDRISC), respectively. These results will guide national cardiovascular and diabetes prevention strategies, and will be available for government agencies to help in the implementation of public health policies.
委内瑞拉心血管代谢健康研究(EVESCAM)是委内瑞拉首次开展的全国性人口调查,旨在调查糖尿病和心血管代谢危险因素的患病率及其与生活方式的关系。这是一项横断面整群抽样研究,招募了4454名年龄≥20岁的参与者。数据由经过培训的卫生专业人员和医学生在社区医疗中心收集。在获得知情同意后,从每个受试者收集的数据包括结构化问卷(临床、人口统计学、身体活动、营养和心理方面)、人体测量指标(体重、身高和腰围)、通过生物电阻抗测量的体脂、握力、血压、心电图以及生化指标测量(标准75克口服葡萄糖耐量试验、总胆固醇、高密度脂蛋白胆固醇、低密度脂蛋白胆固醇和甘油三酯)。这些数据将用于估计超重、肥胖、糖尿病前期、糖尿病、高血压、血脂异常、肌肉减少症和代谢综合征的患病率;并研究它们与生活方式因素的关系。将分别使用弗雷明汉冠心病风险评分和芬兰糖尿病风险评分的拉丁美洲改编版(LA-FINDRISC)来估计冠心病风险和血糖调节受损情况。这些结果将指导国家心血管疾病和糖尿病预防策略,并且可供政府机构用于协助实施公共卫生政策。